Literature DB >> 8789388

Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats.

F J Dowell1, D Henrion, M Duriez, J B Michel.   

Abstract

1. Chronic inhibition of nitric oxide synthase (NOS) induces a sustained hypertension in rats. We studied the effects of chronic inhibition on the in vitro vasoreactivity of mesenteric resistance arteries in Wistar rats. We also investigated the effects of acute in vitro NOS inhibition in these vessels. 2. Acute NOS inhibition (N omega-nitro-L-arginine, L-NOARG, 10 microM) had no effect on the contractile response to KCl (125 mM), enhanced the response to the phorbol ester, phorbol dibutyrate (1 microM; 69 +/- 9% of KCl response, n = 6; 38 +/- 7% control, n = 6, P < 0.05), increased sensitivity to phenylephrine (EC50: 1.68 +/- 0.14 microM, n = 5; 2.35 +/- 0.23 microM control, n = 5, P < 0.05) and sodium nitroprusside (SNP; EC50 1.79 +/- 0.61 nM, n = 6; 20.44 +/- 6.87 nM control, n = 6, P < 0.05) and decreased sensitivity to acetylcholine (EC50 123 +/- 12 nM, n = 6; 45 +/- 10 nM control, n = 13, P < 0.05). 3. In contrast, contractile responses to KCl (125 mM; 170 +/- 12 mN mm-3, n = 10; 257 +/- 21 mN mm-3 in control, n = 13, P < 0.005) and phenylephrine (maximum response, 30 microM: 169 +/- 24 mN mm-3, n = 10; 295 +/- 19 mN mm-3 in control, n = 13, P < 0.001) were significantly reduced in magnitude following chronic NOS inhibition. Sensitivity to phenylephrine was not significantly altered. 4. The effects of chronic NOS inhibition (N omega-nitro-L-arginine methyl ester, L-NAME, 10 mg kg-1 daily for 3 weeks) were similar to those of acute NOS blockade with respect to the relaxant responses to SNP and acetylcholine, and also the contraction in response to protein kinase C activation. 5. Chronic inhibition of NOS significantly increased medial cross sectional area of mesenteric resistance arteries (0.013 +/- 0.002 mm2, n = 7; 0.009 +/- 0.0005 mm2 control, n = 15, P < 0.05). 6. Thus, in contrast to the acute effects of NOS inhibition, chronic NOS inhibition results in a down-regulation of the contractile responses to KCl and phenylephrine in mesenteric resistance arteries, despite an increase in medial cross sectional area. However protein kinase C-dependent contraction remains relatively enhanced. Endothelium-dependent relaxation is reduced and endothelium-independent relaxation is enhanced in a manner similar to the effects of acute NOS blockade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789388      PMCID: PMC1909273          DOI: 10.1111/j.1476-5381.1996.tb15196.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

Authors:  U C Garg; A Hassid
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats.

Authors:  N Bank; H S Aynedjian; G A Khan
Journal:  Hypertension       Date:  1994-09       Impact factor: 10.190

4.  Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP.

Authors:  T L Cornwell; E Arnold; N J Boerth; T M Lincoln
Journal:  Am J Physiol       Date:  1994-11

5.  In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats.

Authors:  V Richard; M Hogie; M Clozel; B M Löffler; C Thuillez
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

6.  Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells.

Authors:  V Kolpakov; D Gordon; T J Kulik
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

7.  Evidence that nitric oxide is an endogenous antiangiogenic mediator.

Authors:  E Pipili-Synetos; E Sakkoula; G Haralabopoulos; P Andriopoulou; P Peristeris; M E Maragoudakis
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

8.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

9.  Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.

Authors:  B I Levy; J B Michel; J L Salzmann; M Azizi; P Poitevin; M Safar; J P Camilleri
Journal:  Circ Res       Date:  1988-07       Impact factor: 17.367

10.  Nitric oxide-independent response to acetylcholine by terminal arterioles in rat cremaster muscle.

Authors:  E Vicaut; N Baudry; X Hou
Journal:  J Appl Physiol (1985)       Date:  1994-08
View more
  12 in total

1.  Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arterioles.

Authors:  David G Ingram; Sean C Newcomer; Elmer M Price; Kevin E Eklund; Richard M McAllister; M Harold Laughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-26       Impact factor: 4.733

2.  Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance.

Authors:  F Terzi; D Henrion; E Colucci-Guyon; P Federici; C Babinet; B I Levy; P Briand; G Friedlander
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.

Authors:  M B Hussain; A J Hobbs; R J MacAllister
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 4.  Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

Authors:  Frank T Spradley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

5.  Effects of chronic nitric oxide synthase inhibition on endothelium-dependent and -independent relaxation in arteries that perfuse skeletal muscle of swine.

Authors:  S C Newcomer; J C Taylor; R M McAllister; M H Laughlin
Journal:  Endothelium       Date:  2008 Jan-Feb

6.  Different vasoactive effects of chronic endothelial and neuronal NO-synthase inhibition in young Wistar rats.

Authors:  Sona Cacanyiova; Andrea Berenyiova; Magdalena Malekova; Frantisek Kristek; Ima Dovinova; Peter Krenek; Lenka Pivackova; Ivana Pifkova
Journal:  J Physiol Biochem       Date:  2014-06-28       Impact factor: 4.158

7.  Cardiovascular effects of high-fructose intake in rats with nitric oxide deficiency.

Authors:  Anna Zemančíková; Jozef Török
Journal:  Interdiscip Toxicol       Date:  2014-12-30

8.  Radical Scavenger Capacity of Jabuticaba Fruit (Myrciaria cauliflora) and Its Biological Effects in Hypertensive Rats.

Authors:  Camila Gabriela de Souza; Daniela Medeiros Lobo de Andrade; Juliana Bahia Reis Jordão; Renato Ivan de Ávila; Leonardo Luiz Borges; Boniek Gontijo Vaz; Marize Campos Valadares; Eric de Souza Gil; Edemilson Cardoso da Conceição; Matheus Lavorenti Rocha
Journal:  Oxid Med Cell Longev       Date:  2017-12-20       Impact factor: 6.543

9.  COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats.

Authors:  Emilie Vessières; Anne-Laure Guihot; Bertrand Toutain; Maud Maquigneau; Céline Fassot; Laurent Loufrani; Daniel Henrion
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

10.  Opposite effects of angiotensins receptors type 2 and type 4 on streptozotocin induced diabetes vascular alterations in mice.

Authors:  Mohamad Nasser; Nicolas Clere; Laurent Botelle; James Javellaud; Nicole Oudart; Sébastien Faure; Jean-Michel Achard
Journal:  Cardiovasc Diabetol       Date:  2014-02-10       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.